Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Long-Term Mortality in HIV-Infected Individuals 50 Years or Older : A Nationwide, Population-Based Cohort Study. / Legarth, Rebecca A; Ahlström, Magnus G; Kronborg, Gitte; Larsen, Carsten S; Pedersen, Court; Pedersen, Gitte; Mohey, Rajesh; Gerstoft, Jan; Obel, Niels.

I: Journal of acquired immune deficiency syndromes (1999), Bind 71, Nr. 2, 01.02.2016, s. 213-8.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Legarth, RA, Ahlström, MG, Kronborg, G, Larsen, CS, Pedersen, C, Pedersen, G, Mohey, R, Gerstoft, J & Obel, N 2016, 'Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study', Journal of acquired immune deficiency syndromes (1999), bind 71, nr. 2, s. 213-8. https://doi.org/10.1097/QAI.0000000000000825

APA

Legarth, R. A., Ahlström, M. G., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Mohey, R., Gerstoft, J., & Obel, N. (2016). Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study. Journal of acquired immune deficiency syndromes (1999), 71(2), 213-8. https://doi.org/10.1097/QAI.0000000000000825

Vancouver

Legarth RA, Ahlström MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G o.a. Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2016 feb. 1;71(2):213-8. https://doi.org/10.1097/QAI.0000000000000825

Author

Legarth, Rebecca A ; Ahlström, Magnus G ; Kronborg, Gitte ; Larsen, Carsten S ; Pedersen, Court ; Pedersen, Gitte ; Mohey, Rajesh ; Gerstoft, Jan ; Obel, Niels. / Long-Term Mortality in HIV-Infected Individuals 50 Years or Older : A Nationwide, Population-Based Cohort Study. I: Journal of acquired immune deficiency syndromes (1999). 2016 ; Bind 71, Nr. 2. s. 213-8.

Bibtex

@article{cae99c6fecbf404d8644f977757140c7,
title = "Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study",
abstract = "BACKGROUND: Although the prevalence of HIV-infection among individuals ≥ 50 years of age has increased, the impact of HIV-infection on risk of death in this population remains to be established. Our aim was to estimate long-term mortality among HIV-infected individuals who were 50 years or older, when compared with an individually-matched cohort from the background population.METHODS: Population-based cohort-study including HIV-infected individuals ≥ 50 years, who were alive 1 year after HIV-diagnosis (n = 2440) and a comparison cohort individually-matched by age and gender extracted from the background population (n = 14,588). Cumulative survival was evaluated using Kaplan-Meier method and Mortality Rate Ratios (MRRs) were estimated using Cox Regression Models. Study period 1996-2014.RESULTS: Estimated median survival time from age 50 years for HIV-infected individuals increased from 11.8 years (95% CI: 10.2 to 14.5) during 1996-1999 to 22.8 years (20.0-24.2) in 2006-2014. MRR decreased with increasing age from 3.8 (3.1-4.7) for 50-55 years to 1.6 (1.0-2.6) for 75-80 years. In a cohort of well-treated HIV-infected individuals ≥ 50 years without AIDS-defining events or comorbidity at study inclusion (n = 517). MRR was 1.7 (1.2-2.3) compared with population controls without comorbidity.CONCLUSION: Among HIV-infected individuals estimated median survival time from age 50 years has increased by more than 10 years from 1996-1999 to 2006-2014, but is still substantially lower than in the background population. Even among well-treated HIV-infected individuals ≥ 50 years without comorbidity or AIDS-defining events the estimated median survival time remains lower than in the general population.",
author = "Legarth, {Rebecca A} and Ahlstr{\"o}m, {Magnus G} and Gitte Kronborg and Larsen, {Carsten S} and Court Pedersen and Gitte Pedersen and Rajesh Mohey and Jan Gerstoft and Niels Obel",
year = "2016",
month = feb,
day = "1",
doi = "10.1097/QAI.0000000000000825",
language = "English",
volume = "71",
pages = "213--8",
journal = "J A I D S",
issn = "1525-4135",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Long-Term Mortality in HIV-Infected Individuals 50 Years or Older

T2 - A Nationwide, Population-Based Cohort Study

AU - Legarth, Rebecca A

AU - Ahlström, Magnus G

AU - Kronborg, Gitte

AU - Larsen, Carsten S

AU - Pedersen, Court

AU - Pedersen, Gitte

AU - Mohey, Rajesh

AU - Gerstoft, Jan

AU - Obel, Niels

PY - 2016/2/1

Y1 - 2016/2/1

N2 - BACKGROUND: Although the prevalence of HIV-infection among individuals ≥ 50 years of age has increased, the impact of HIV-infection on risk of death in this population remains to be established. Our aim was to estimate long-term mortality among HIV-infected individuals who were 50 years or older, when compared with an individually-matched cohort from the background population.METHODS: Population-based cohort-study including HIV-infected individuals ≥ 50 years, who were alive 1 year after HIV-diagnosis (n = 2440) and a comparison cohort individually-matched by age and gender extracted from the background population (n = 14,588). Cumulative survival was evaluated using Kaplan-Meier method and Mortality Rate Ratios (MRRs) were estimated using Cox Regression Models. Study period 1996-2014.RESULTS: Estimated median survival time from age 50 years for HIV-infected individuals increased from 11.8 years (95% CI: 10.2 to 14.5) during 1996-1999 to 22.8 years (20.0-24.2) in 2006-2014. MRR decreased with increasing age from 3.8 (3.1-4.7) for 50-55 years to 1.6 (1.0-2.6) for 75-80 years. In a cohort of well-treated HIV-infected individuals ≥ 50 years without AIDS-defining events or comorbidity at study inclusion (n = 517). MRR was 1.7 (1.2-2.3) compared with population controls without comorbidity.CONCLUSION: Among HIV-infected individuals estimated median survival time from age 50 years has increased by more than 10 years from 1996-1999 to 2006-2014, but is still substantially lower than in the background population. Even among well-treated HIV-infected individuals ≥ 50 years without comorbidity or AIDS-defining events the estimated median survival time remains lower than in the general population.

AB - BACKGROUND: Although the prevalence of HIV-infection among individuals ≥ 50 years of age has increased, the impact of HIV-infection on risk of death in this population remains to be established. Our aim was to estimate long-term mortality among HIV-infected individuals who were 50 years or older, when compared with an individually-matched cohort from the background population.METHODS: Population-based cohort-study including HIV-infected individuals ≥ 50 years, who were alive 1 year after HIV-diagnosis (n = 2440) and a comparison cohort individually-matched by age and gender extracted from the background population (n = 14,588). Cumulative survival was evaluated using Kaplan-Meier method and Mortality Rate Ratios (MRRs) were estimated using Cox Regression Models. Study period 1996-2014.RESULTS: Estimated median survival time from age 50 years for HIV-infected individuals increased from 11.8 years (95% CI: 10.2 to 14.5) during 1996-1999 to 22.8 years (20.0-24.2) in 2006-2014. MRR decreased with increasing age from 3.8 (3.1-4.7) for 50-55 years to 1.6 (1.0-2.6) for 75-80 years. In a cohort of well-treated HIV-infected individuals ≥ 50 years without AIDS-defining events or comorbidity at study inclusion (n = 517). MRR was 1.7 (1.2-2.3) compared with population controls without comorbidity.CONCLUSION: Among HIV-infected individuals estimated median survival time from age 50 years has increased by more than 10 years from 1996-1999 to 2006-2014, but is still substantially lower than in the background population. Even among well-treated HIV-infected individuals ≥ 50 years without comorbidity or AIDS-defining events the estimated median survival time remains lower than in the general population.

U2 - 10.1097/QAI.0000000000000825

DO - 10.1097/QAI.0000000000000825

M3 - Journal article

C2 - 26334734

VL - 71

SP - 213

EP - 218

JO - J A I D S

JF - J A I D S

SN - 1525-4135

IS - 2

ER -

ID: 161247126